Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

EsbaTech gets €7.3mm ($6.6mm) with second round

Executive Summary

EsbaTech AG (drug discovery) has raised €7.3mm ($6.6mm) with its second private placement. The lead investor, the Immunology Fund of Lombard Odier & Cie, was joined by HBM BioVentures, BSI New Biomedical Frontiers, private investor Peter Ohnemus, plus returning investor Novartis Venture Fund.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register